Inflammation and atherosclerosis: fulfilling Koch's postulates

Ther Adv Cardiovasc Dis. 2018 Jan;12(1):5-6. doi: 10.1177/1753944717744740. Epub 2017 Nov 30.

Authors

Ishwarlal Jialal¹, Naval K Vikram²

Affiliations

¹ College of Medicine, California Northstate University, 7300 Taron Road, Elk Grove, CA 95757, USA.
² All India Institute of Medical Sciences, New Delhi, India.

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Atherosclerosis / blood
Atherosclerosis / diagnosis
Atherosclerosis / drug therapy*
Atherosclerosis / mortality
Biomarkers / blood
Humans
Inflammation / blood
Inflammation / diagnosis
Inflammation / drug therapy*
Inflammation / mortality
Inflammation Mediators / blood
Lipids / blood
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biomarkers
Inflammation Mediators
Lipids
canakinumab